There is now no doubt that stress influences the functions of the nervous and immune systems. Stress-induced changes in the operation of these systems has been studied in experimental models and clinical practice in patients after prolonged psychoemotional experiences. There are many reports of studies on the possibility that stress has positive and negative effects on the body's defensive functions [28, 31, 32] , the nature of their influences depending on the intensity and duration of exposure to the stressor and on the initial functional status [1, 28] . The use of these models of experimental stress allows different neurotransmitters and neuropeptides to be studied, along with their roles in the mechanisms of the brain's reactions to stressors.
There is now no doubt that stress influences the functions of the nervous and immune systems. Stress-induced changes in the operation of these systems has been studied in experimental models and clinical practice in patients after prolonged psychoemotional experiences. There are many reports of studies on the possibility that stress has positive and negative effects on the body's defensive functions [28, 31, 32] , the nature of their influences depending on the intensity and duration of exposure to the stressor and on the initial functional status [1, 28] . The use of these models of experimental stress allows different neurotransmitters and neuropeptides to be studied, along with their roles in the mechanisms of the brain's reactions to stressors.
There are grounds for suggesting that the neurotransmitters orexin A and orexin B, discovered in 1998, have roles in mediating the brain's responses to stressors. Most orexincontaining neurons were found to be located in the lateral hypothalamic area (LHA) [15] . Small numbers were also found in the paraventricular (PVN) and dorsomedial (DMN) nuclei and the posterior hypothalamic field (PH) [26] .
Studies using an immunohistochemical method of detecting c-Fos protein and orexin A in brain cells demonstrated selectivity of the responses of orexin-containing neurons in conditions of different stress-inducing treatments. These treatments were shown to activate some hypothalamic orexin-containing neurons with intensities which varied depending on the strength and duration of the treatment applied [6, 13, 23, 38] . Application of cooling and movement restriction to young rats led to increases in the numbers of hypothalamic c-Fos-positive orexin-containing cells, by 15% and 24%, respectively [8, 29] , while pain stimuli activated more than 90% of hypothalamic orexincontaining neurons [38] . However, changes in the intensity of preproorexin mRNA synthesis were not so unambiguous: movement restriction, cooling, hypoglycemia, and restricted feeding all increased the quantity of preproorexin mRNA, while fear reactions, conversely, decreased the quantity [8, 13, 29, 38] . The selectivity of the responses of orexin-containing neurons to stressors of different types may be associated with functional differences in hypothalamic orexin-containing neuron populations.
Intraventricular administration of orexin leads to stimulation of adrenocorticotropic hormone (ACTH) secretion [8, 14, 29, 30] , activation of the HHAS [14] , and increases in plasma corticosterone levels [2, 7, 10, 11, 13, 14, 24, 27] , as well as an increase in the number of c-Fos-positive neurons in the parvocellular part of the PVN, whose membranes have been shown to bear orexin receptors [36] .
Recently published data provide evidence that orexincontaining neurons not only have roles in stress responses, but are also involved in the processes of thermoregulation and heat production [5, 12, [18] [19] [20] [21] [22] 34] . However, results obtained in studies demonstrating the involvement of orexin-containing neurons in thermoregulatory processes are contradictory. The dorsomedial (DMH) and paraventricular (PVN) nuclei, along with the lateral and posterior (PH) hypothalamic fields, which contain orexin-containing neurons, are known to be associated with heat production [3, 4, 9, 35, 37] . In different conditions, intraventricular orexin A can induce either increases or decreases in an animal's temperature [3, 4, 9, 35, 36] . Preproorexin gene knockout mice lack circadian changes in body temperature [16] . Along with data providing evidence that orexin is involved in thermoregulation, there are data indicating the controlling action of the cortex on the thermoregulatory effect of orexin: suppression of cortical activity in the frontal area blocks the increase in body temperature induced by intraventricular orexin A [37] . Furthermore, intraventricular orexin A decreased fever evoked by LPS [12] .
Movement restriction and cooling and combined stress (movement restriction combined with cooling) are known to lead to the development of a severe stress reaction, initiating significant changes in plasma catecholamine and glucocorticoid levels [25, 32] . Use of an appropriate experimental model of stress induction will widen our concepts of the level of involvement of hypothalamic orexin-containing neurons in the development of the set of reactions occurring in the brain during the formation of the response to stress. This is a relevant question to address, as it aims to discover the mechanisms by which hypothalamic orexin-synthesizing neurons react to changes occurring in the central nervous system on the background of exposure to a stressor and may explain whether orexin-containing neurons are involved in the process of thermoregulation, as some of these neurons are known to be located in hypothalamic areas with this function.
We report here our studies of hypothalamic orexincontaining neurons using an immunohistochemical method allowing the numbers of orexin-containing cells to be measured and the locations of these neurons in different hypothalamic structures to be identified, which is needed for understanding the nature of the responses of defined groups of neurons to defined treatments.
The aim of the present work was to study the responses of orexin-containing neurons located in different parts of the peripheral region of the lateral hypothalamus in the mechanisms underlying the brain's reactions to movement restriction and experimental cooling.
To address these questions the following were determined:
1) the numbers of orexin-positive neurons in the hypothalamus of intact animals;
2) the immunoreactivity of orexin-containing neurons in the hypothalamus of animals after movement restriction;
3) the immunoreactivity of orexin-containing neurons in the hypothalamus of animals subjected to movement restriction and cooling.
METHODS
Studies were performed using 18 male Wistar rats weighing 200-250 g. Animals were kept in animal-house conditions at room temperature with a 12-h dark/light cycle and free access to water and food. Experiments were started at 11:00 to avoid differences associated with diurnal variations in orexin contents in hypothalamic cells. The experimental animals were divided into two groups each of six animals. Animals of group 1 were subjected to movement restriction for 1 h. Animals of group 2 were also subjected to movement restriction for 1 h, but after the first 20 min they were additionally cooled to -20°C for the last 20 min. After cooling, animals of group 2 were placed in containers restricting mobility and were kept there for 20 min. The experimental animals were then placed in their usual cages and, after 1 h, were anesthetized with phenobarbital (i.p., 60 μg/kg). Intact animals were anesthetized simultaneously with the experimental animals, at 13:00. Intracardiac perfusion was performed using warm physiological saline containing heparin (10 U/ml), followed by cool fixative solution (100 ml of 4% paraformaldehyde in 0.1 M phosphate-buffered saline (PBS) and 0.2% picric acid pH 7.4). Brains were removed 1 h after perfusion and immersed in fresh fixative solution not containing picric acid for 12 h at +4°C, after which frontal cryotome sections (30 μm) were cut.
Hypothalamic orexin-containing neurons were detected using an avidin-biotin method. Primary antibodies were rabbit antibodies to orexin A (1:5000; Sigma), while secondary antibodies were monoclonal antirabbit immunoglobulins (clone RG-16) conjugated with biotin (1:1000; Sigma), which were detected using an avidin-peroxidase label. The substrate for peroxidase was 3,3'-diaminobenzidine (DAB; Sigma). Sections were then mounted on slides and embedded in Canada balsam (Sigma). Immunohistochemically stained brain sections were used to assess the numbers of orexin-positive cells in all hypothalamic structures.
Labeled neurons had a dark brown color. Counting of cells was limited to those cells with clearly stained outlines and at least one third filled with orexin granules. Random errors occurring during preparation of sections were minimized by counting the numbers of orexin-containing neurons in all brain sections from levels 26-32 as defined by a rat brain atlas [33] . Brain sections from animals of all groups were stained simultaneously. Staining times were strictly standardized.
Changes in the immunoreactivity of orexin-containing cells were assessed in terms of three parameters: 1) the mean number of orexin-containing neurons per section at a defined level;
2) the mean number of orexin-containing neurons in different hypothalamic structures;
3) the mean number of orexin-containing neurons in different zones of hypothalamic structures.
The numbers of orexin-containing neurons in hypothalamic structures located on frontal brain sections at Swanson atlas levels 28-32 were analyzed statistically.
Experimental results were processed using standard statistical methods.
RESULTS
Orexin-immunoreactive neurons were characterized by variations in shape: spherical, ellipsoid, triangular. In animals of the intact group, neurons were filled with orexin granules and had clearly defined outlines. It should be noted that the ability to detect these cells as orexin-positive neurons in hypothalamic structures depends on the quantity of orexin A neurotransmitter present within the cells, and this method of staining orexin-positive neurons did not allow neurons containing small quantities of the neurotransmitter to be detected. Thus, changes in the numbers of orexin-positive cells in hypothalamic structures measured immunohistochemically reflect changes in the extent to which they can be visualized, or their immunoreactivity, which depends on the quantity of orexin within the cell.
Orexin-containing neurons have been shown to be located mainly in the peripheral part of the lateral hypothalamic field (LHA) (Fig. 1) . The mean number of cells in this area was 60-70 neurons per brain section. Small numbers were also present in the paraventricular (PVN) and dorsomedial (DMH) nuclei and the posterior field of the hypothalamus (PH). Orexin-containing neurons located close to the third ventricle were smaller and had lower distribution densities than neurons located in the LHA. The PVH contained only occasional orexin-containing neurons, while the mean number among DMH cells amounted to 5-7 cells per level 28 brain section and that in the PH was 20-25 cells per level 31 brain section. The largest numbers of orexin-positive cells were found in structures located in sections at levels 28, 29, and 30 ( Fig. 2) .
Hypothalamic Orexin-Positive Neurons after Movement Restriction and Cooling
After movement restriction, animals showed a decrease in the level of immunoreactivity of orexin-containing neurons in hypothalamic structures on brain sections at level 28, which was apparent as a reduction in the visualization of orexin-containing neurons located in this areas and a corresponding reduction in the number of orexin-positive neurons detected.
In hypothalamic structures located on sections at level 28, the immunoreactivity of orexin-containing neurons decreased by 17%. In contrast, brain sections from level 31 showed a 19% increase in the number of orexin-positive neurons. Animals subjected to combined treatmentsmovement restriction and cooling -showed a 31% increase in the number of orexin-positive neurons in hypothalamic structures located in brain sections at level 28. Hypothalamic structures on rat brain sections located at level 31 showed a tendency to reductions in the immunoreactivity of orexin-containing neurons (by 13%). There were no changes in the immunoreactivity of orexin-containing neurons in hypothalamic structures on sections at levels 29, 30, and 32.
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Distribution of Orexin-Containing Neurons in Various Rat Hypothalamic Structures on Movement Restriction and Combined Movement Restriction with Cooling
As noted above, orexin-containing neurons were mainly located in the LHA, DMH, and PH. The distribution of orexin-containing neurons in the hypothalamus was assessed by counting orexin-positive neurons located in different structures (Fig. 3) .
Differential evaluation of the numbers of orexin-positive cells in the hypothalamic structures studied established that movement restriction was followed by a 17% reduction in the immunoreactivity of orexin-containing neurons in the LHA on brain sections at level 28 (Fig. 3) , as compared with the number in intact animals. After combined treatment, the number of orexin-containing neurons located in the LHA on brain sections at level 28 increased by 29% compared with the number in animals subjected to movement restriction alone (Fig. 3) .
In the DMH on brain sections at level 29, the number of orexin-positive neurons after movement restriction increased by 39% compared with the number in intact animals (Fig. 3) . In the DMH on sections at level 31, the number of orexin-positive neurons in these conditions increased by 138% compared with the number in animals of the control group. After combined treatment, the number of orexin- containing neurons visualized in the DMH on brain sections at level 28 increased by 65% (Fig. 3) .
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Distribution of Orexin-Containing Neurons in Different Zones of the Hypothalamic Structures Studied in Conditions of Movement Restriction and Combined Movement Restriction and Cooling
Analysis of the numbers of orexin-positive cells in different zones of hypothalamic structures (LHA, DMH, PH, PVH) showed that the numbers changed in different ways in different zones of individual structures after exposure to stressors.
Analysis of the numbers of orexin-containing neurons located in defined zones of hypothalamic structures on brain sections at level 28 revealed a 31% decrease in neuron immunoreactivity in the LHAd 1 h after the end of movement restriction (Fig. 4) . Combined treatment led to increases in the immunoreactivity of orexin-containing neurons located on brain sections at level 28 in the LHAd (59%), DMH (65%), and LHAjd (41%) (Fig. 4) . In those brain structures located on sections at level 29, the number of hypothalamic orexin-positive neurons after movement restriction remained unchanged. However, analysis of changes in the immunoreactivity of orexin-containing neurons in different zones of the same structures after this treatment revealed differences. In the LHA on brain sections at level 28, the number of immunoreactive orexin-containing neurons increased by 76% in area LHAs, while there was a 63% decrease in the number of orexin-positive cells in the LHAm (Fig. 4) .
In hypothalamic structures of rats located on sections at level 29, combined treatment was followed by changes in area LHAm, where the number of orexin-containing neurons increased by 135% (Fig. 4) . The number of orexin-pos- itive cells in hypothalamic structures on sections at level 31 increased by 19% after movement restriction, mainly due to a 41% increase in the degree of immunoreactivity of orexin-containing neurons in the dorsal part of the PH (Fig. 4) .
In the dorsal part of the PH, the immunoreactivity of orexin-containing neurons located on brain sections at level 31 decreased by 39%. However, the number of orexin-containing neurons in the DMH increased by 138%. These data suggest that changes in the immunoreactivity of orexin-containing neurons in the rat hypothalamus, both in conditions of movement restriction and after combined movement restriction and cooling, occurred mainly in structures of the dorsal part of the periforniceal area of the hypothalamus (Fig. 4 ). There were no changes in the immunoreactivity of hypothalamic orexin-containing neurons located in structures beneath the fornix.
Detailed analysis of the rat hypothalamus on brain sections corresponding to level 29 after stressors demonstrated changes in the immunoreactivity of orexin-containing neurons only in individual structures and zones of the hypothalamus, without changes in the total number of orexin-positive neurons located on sections at this level. Hypothalamic structures located in brain sections at level 29 showed a 76% increase in the number of orexin-positive neurons in the LHAs; in contrast, there was a 63% decrease in the LHAm.
These results lead to the conclusion that changes in the immunoreactivity of rat hypothalamus orexin-containing neurons, both in movement restriction and combined use of movement restriction and cooling, occurred mainly in structures of the dorsal part of the periforniceal area of the hypothalamus (Fig. 5) . The immunoreactivity of hypothalamic orexin-containing neurons located in structures beneath the fornix did not change.
The immunoreactivity of rat hypothalamus orexincontaining neurons increased in the LHAd, LHAjd, DMHa, and LHAm on combined use of movement restriction and cooling. In the LHAd, on sections corresponding to level 28, as well as the LHAm and PH, on sections corresponding to levels 29 and 31, respectively, combined movement restriction and cooling led to recovery of the number of orexin-positive neurons to the level typical of intact animals. In the DMHa and LHAjd, on sections corresponding to level 28, in the LHAs and DMHa, on sections corresponding to level 29, as well as in the DMHa, on sections corresponding to level 31, the numbers of orexin-positive neurons increased on movement restriction and cooling.
DISCUSSION
Analysis of the data obtained here suggests that the changes detected 1 h after exposure to stressors appear to be due to impairments in the balance between the processes of synthesis and utilization of orexin A in orexin-containing neurons. Changes in the ratio of synthesis and utilization of orexin A in hypothalamic orexin-containing neurons led to decreases or increase in their immunoreactivity 1 h after experimental treatments. These types of treatments were found to produce selective changes in the level of immunoreactivity of orexin-containing neurons, which is evidence for the functional heterogeneity of the orexin-containing neuron population located in the tuberal area of the hypothalamus.
The discrete nature of the changes occurring in orexincontaining neurons both in movement restriction and combined movement restriction and cooling may be evidence for the existence of functionally diverse populations of orexin-containing cells which appear to send projections to different areas of the brain.
The immunoreactivity of orexin-containing neurons located in the DMH, PH, and some zones of the LHA changed significantly in movement restriction and cooling. The dorsomedial nucleus (DMH), the lateral hypothalamic area (LHA), and posterior field (PH) of the hypothalamus are known to be involved in the process of heat production [3, 4, 9, 35, 37] . Changes in the immunoreactivity of orexin-containing neurons located in areas involved in regulating the heat production system provide grounds for suggesting that orexin-containing neurons may be involved in thermoregulation processes.
The use of detailed mapping of orexin-containing neurons located in different zones of hypothalamic structures provided the first demonstration of functionally diverse populations of orexin-containing neurons, not seen using simple quantitative assessment of orexin-containing neurons located on brain sections from defined levels.
The set of results obtained here provides evidence for the involvement of hypothalamic orexin-containing neurons in the mechanisms underlying the brain's responses to movement restriction and combined movement restriction and cooling. Individual structures activated by these treatments were identified and the nature and degree of the involvement of orexin-containing neurons in the mechanisms underlying the brain's reactions in these types of stressors were assessed. Differences in their patterns of activation on movement restriction and combined movement restriction and cooling were seen, which is important for understanding the mechanisms of the brain's responses in these conditions.
